S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

BTAI BioXcel Therapeutics Inc

0.409

0.017 (4.34%)

Jan 03 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more BioXcel Therapeutics Charts.

BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more BioXcel Therapeutics Charts.

BioXcel Therapeutics Inc News

Form DEF 14A - Other definitive proxy statements
Monday 30 December 2024 (5 days ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Wednesday 18 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 16 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 25 November 2024 (1 month ago) • Edgar (US Regulatory)

BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering
Friday 22 November 2024 (1 month ago) • GlobeNewswire Inc.

BioXcel Therapeutics Announces Proposed Public Offering
Thursday 21 November 2024 (1 month ago) • GlobeNewswire Inc.

More BioXcel Therapeutics Inc News Articles

Global Developments (PK)

Tonix Pharmaceuticals

Fannie Mae (QB)

Anavex Life Sciences

Bioelectronics (PK)

Code Green Apparel (PK)

GBT Technologies (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions